CHMP Issues Positive Opinion Recommending DARZALEX(r) (daratumumab) for Relapsed and Refractory Multiple Myeloma
CHMP issued positive opinion for DARZALEX for relapsed and refractory multiple myeloma Final decision from European Commission expected in the coming months COPENHAGEN, Denmark, April 1, 2016 (GLOBE NEWSWIRE) -- Genmab A/S (Nasdaq Copenhagen:GEN) …